Home > Healthcare > Medical Devices > Diagnostic Devices > at home drug of abuse testing market
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of At-home Drug of Abuse (DOA) Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
At-Home Drug of Abuse Testing Market size was valued at USD 3.5 billion in 2022 and is estimated to register around 7% CAGR between 2023 and 2032. increasing production of illicit drugs will drive market growth.
As the prevalence of cannabis use and other illicit drugs emphasizes the need for effective preventive measures and early interventions will lead to elevated demand for drug of abuse testing. Furthermore, governments and public health authorities worldwide have been implementing various initiatives to combat drug abuse and its related consequences. These initiatives include awareness campaigns, treatment programs, and drug testing programs in workplaces and schools. The increased emphasis on drug testing has further propelled the adoption of at-home drug of abuse (DOA) testing kits as an effective tool to support these efforts.
The global market for at-home drug of abuse testing was reached USD 3.5 billion in 2022 and is estimated to account for USD 7.2 billion by 2032, as it allows individuals to conduct drug tests in the privacy of their own homes.
The test strips segment garnered USD 1.7 billion in the year 2022, as it offers quick and straightforward drug testing procedures, providing convenience to individuals.
U.S. at-home drug of abuse testing market exceeded USD 1.2 billion in 2022 and is predicted to witness substantial growth through 2032, owing to high prevalence of drug abuse and substance use disorders in the country.
Confirm BioSciences, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., bioM